All In MedTech

Device Trial Radar · NCT04035356

HAART Annuloplasty Device Valve Repair Registry

Safety and Performance of Aortic Valve Repair Using the HAART Aortic Annuloplasty Devices - A Registry Study

Last checked: Nov 20, 2026Latest source record: Aug 9, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

183

Actual

Start

Sep 22, 2020

Primary completion

Jul 25, 2024

Study completion Jul 25, 2024

Sponsor

Lead sponsor
Biostable Science & EngineeringNot on our public-company list
Sponsor type
Industry
First posted
Jul 29, 2019

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Multicenter US registry study to assess procedure success and long-term (10-year) performance of the HAART 200 and HAART 300 Aortic Annuloplasty Devices when used during aortic valve repair in a routine cardiovascular practice setting.

Conditions

  • Aortic Valve Insufficiency
  • Aortic Aneurysm

Interventions

  • Aortic valve repairDevice

    Use of a HAART Aortic Annuloplasty Device in patients undergoing aortic valve repair surgery

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Freedom from aortic valve reoperationTime frame: 10 years

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Franciscan Health Indianapolis

    Indianapolis, Indiana

4 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.